To begin to characterize these distinct MCL cell populations, we co-cultured MS-5 and MCL cells and analyzed the suspension and CAFC populations for surface expression of CD45, T-cell (CD3, CD5), B-cell (CD19, CD23) and stem cell markers (CD34, CD133) by flow cytometry. The gene discussed is CD19; the disease is mantle cell lymphoma.